---
title: In a rat model of bypass DuraGraft ameliorates endothelial dysfunction of arterial
  grafts
date: '2024-07-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38956161/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240703182124&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Coronary artery bypass surgery can result in endothelial dysfunction
  due to ischemia/reperfusion (IR) injury. Previous studies have demonstrated that
  DuraGraft helps maintain endothelial integrity of saphenous vein grafts during ischemic
  conditions. In this study, we investigated the potential of DuraGraft to mitigate
  endothelial dysfunction in arterial grafts after IR injury using an aortic transplantation
  model. Lewis rats (n = 7-9/group) were divided in three groups. Aortic arches from
  ...
disable_comments: true
---
Coronary artery bypass surgery can result in endothelial dysfunction due to ischemia/reperfusion (IR) injury. Previous studies have demonstrated that DuraGraft helps maintain endothelial integrity of saphenous vein grafts during ischemic conditions. In this study, we investigated the potential of DuraGraft to mitigate endothelial dysfunction in arterial grafts after IR injury using an aortic transplantation model. Lewis rats (n = 7-9/group) were divided in three groups. Aortic arches from ...